FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 7, 2011, Pages 1827-1831

  Mukda, Ekchol ^a   Pintaraks, Katsarin ^b   Sawangpanich, Rachchadol ^c   Wiangnon, Surapon ^d   Pakakasama, Samart ^c  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Division of Diagnostic Clinical Microscopy   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Acute myeloblastic leukemia; Childhood; Flt3; Mutations; Npm1

Indexed keywords

CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEOPHOSMIN; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; FEMALE; GENETICS; HUMAN; INFANT; MALE; MUTATION; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 84864337534     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arrigoni P, Berreta C, Silvestri D, et al (2003). FLT3 internal tandem duplication in childhood acute myeloid leukemia: association with hyperleukocytosis in acute promyelocytic leukemia. Br J Hematol, 120, 89-92.
2. Braoudaki M, Papathanassiou C, Katsibardi K, et al (2010). The frequency of NPM1 mutations in childhood acute myeloid leukemia. J Hematol Oncol, 3, 41-5.
3. Brown P, Mclntyre E, Rau R, et al (2007). The incidence and clinical significance of nucleoplasmin mutations in childhood AML. Blood, 110, 979-85.
4. Brown P, Rau R (2009). Nucleoplasmin (NPM1) mutations in adult and childhood acute myeloid leukemia: towards definition of a new leukemia entity. Hematol Oncol, 27, 171-81.
5. Cazzaniga G, Dell'Oro MG, Mecucci C, et al (2005). Nucleoplasmin mutations in childhood acute myelogenous leukemia with normal kkaryotype. Blood, 106, 1419-22.
6. Chou WC, Tang JL, Lin LI, et al (2006). Nucleoplasmin mutations in de no vo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res, 66, 3310-6.
7. Döhner K, Schlenk FR, Hanbdank M, et al (2005). Mutant nucleoplasmin (NPM1) predict favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutation. Blood, 106, 3740-6.
8. Döhner K, Döhner H (2008). Molecular characterization of acute myeloid leukemia. Haematologica, 93, 976-82.
9. Estey E, Döhner H (2006). Acute myeloid leukemia. Lancet, 368,1894-907.
10. Falini B, Mecucci C, Tiacci E, et al (2005). Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Eng J Med, 352, 254-66.
11. Falini B, Bolli N, Liso A, et al (2009). Alteration nucleoplasmin transport in acute myeloid leukemia with mutated NPM1: molecular basis and clinical implications. Leukemia, 23, 1731-43.
12. Gaidzik V, Döhner K (2008). Prognostic implication of gene mutations in acute myeloid leukemia with normal cytogenetics. Semin in Oncol, 35, 346-55.
13. Gilliland DG, Griffin JD (2002). The roles of FLT3 in hematopoiesis and leukemia. Blood, 100,1532-42.
14. Iwai T, Yokota S, Nakao M, et al (1999). Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. Leukemia, 13, 38-43.
15. Ishikawa Y, Kiyoi H, Tsujimura A,et al (2009). Comprehensive analysis of coorperating gene mutations beween class I and class II in de novo acute myeloid leukemia. Eur J Hematology, 83, 90-8.
16. Kang HJ, Hong SH, Kim IH, et al (2005). Prognostic significance of FLT3 mutations in pediatric non-promylocytic acute myeloid leukemia. Leuk Res, 29, 617-23.
17. Kiyoi H, Naoe T, Yokota S, et al (1997). Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia, 11, 1447-52.
18. Mead AJ, Linch DC, Hills RK, et al (2007). FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia. Blood, 110, 1262-70.
19. Mori Y, Yoshimoto G, Kumano T, et al (2007). Distinctive expression of myelomonocytic markers and down-reguration of CD34 in acute myelogenous leukemia with FLT3 tandem duplication and nucleoplasmin. Eur J Heamatol, 79, 17-24.
20. Munoz L, Aventin A, Villamor N, et al (2003). Immunphenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication. Hematologica, 637-645.
21. Parcells WB, Ikeda KA, Simms-Waldrip T, et al (2006). FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem cell, 24, 1174-84.
22. Pui C-H (1995). Childhood leukemia. N Engl J Med, 332, 1618-30.
23. Rachel R, Patrick B (2009). Nucleoplasmin (NPM1) mutations in adult and childhood acute myeloid leukemia: toward definition of a new leukemia entity. Hematol Oncol, 27, 171-81.
24. Renneville A, Roumier C, Biggio V, et al (2008). Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia, 22, 915-31.
25. Rosemary EG, Claire G, Christopher A, et al (2008). The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in large cohort of young adult patient with acute myeloid leukemia. Blood, 111, 2776-84.
26. Shimada A, Taki T, Kubota C, et al (2007). No nucleoplasmin mutations in pediatric acute myeloid leukemia with normal karyptype: a study of the Japanese Childhood AML Cooperative study group. Leukemia, 21, 1307-7.
27. Thiede C, Steudel C, Mohr B, et al (2002). Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-35.
28. Thiede C, Koch S, Creutzig E, et al (2006). Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 107, 4011-20.
29. Thiede C, Creutzig E, Reinhardt D, et al (2007). Different types of NPM1 mutations in children and adult: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12. Leukemia, 21, 266-7.
30. Wang L, Lin D, Zhang X, et al (2005). Analysis of FLT3 internal tandem duplication and D835 mutations in Chinease acute leukemia patients. Leuk Res, 29, 1393-8.
31. Weina Ch,Georgios ZR, Medeiros JL (2006). Nucleophosmin Gene Mutations in Acute Myeloid Leukemia. Arch Pathol Lab Med, 130, 1687-92.
32. Whitman PS, Ruppert SA, Radmacher DM, et al (2008). FLT3D835/I836 mutations are associated with poor disease-free survival and a distinct gene expression signature among younger adult with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications. Blood, 111, 1552-59.
33. Yamada M, Matsuo K, Suzuki T, et al (2005). Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for myeloid leukemia: ameta-analysis. Leukemia, 19, 1345-49.
34. Yamamoto Y, Kiyoi H, Nakano Y, et al (2001). Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434-9.
35. Zwann CM, Meshinchi S, Radich JP, et al (2003). FLT3 internal tandem mutations in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood, 98,1752-9